PTC Therapeutics, Inc. (NASDAQ:PTCT) Receives $91.36 Average PT from Analysts
Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) have been given an average rating of “Moderate Buy” by the fourteen research firms that are covering the firm, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell rating, one has assigned a hold rating, ten have given a buy rating […]
9 Jul 09:41 · The Markets Daily